Amiloride
آمیلوراید
❤️ Cardiovascular SystemPotassium-sparing diuretic
Market / country: 🇺🇸 USA
Midamor (US)
🧮 Dose calculator
Hypertension · Regimen source: FDA Amiloride · Dosage and Administration
- • With food. Usually added to a kaliuretic diuretic; up to 10 mg (15–20 mg for persistent hypokalaemia, with electrolyte monitoring). FDA Amiloride · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Serum potassium >5.5 mEq/L; other potassium-conserving agents (spironolactone, triamterene) or potassium supplements (except severe hypokalaemia with monitoring); anuria, acute or chronic renal insufficiency, diabetic nephropathy. FDA Amiloride · Contraindications
Warnings
- • Hyperkalaemia (K >5.5 mEq/L), potentially fatal if uncorrected; occurs in about 10% without a kaliuretic diuretic. FDA Amiloride · Warnings
Formulations
- 5 mg tablet — tablet 🇺🇸 USA FDA Amiloride · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Amiloride · Pregnancy
“Pregnancy Category B .”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Amiloride · Nursing Mothers
“Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from amiloride HCl, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Amiloride · Pediatric Use
“Safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Amiloride · Geriatric Use
“In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA070346
- DailyMed (FDA label)FDA Amiloride
- MedlinePlus (NIH)Amiloride
- WHO ATC/DDDC03DB01
- Darooyab (Iran)Amiloride
🇮🇷 Registered in Iran Darooyab · G-1520/Amiloride
Dosage forms with Iranian generic codes, per Darooyab.
- 07083 · AMILORIDE 5MG TAB · قرص آمیلوراید ۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Amiloride · How SuppliedFDA Amiloride · Dosage and AdministrationFDA Amiloride · ContraindicationsFDA Amiloride · WarningsFDA Amiloride · PregnancyFDA Amiloride · Nursing MothersFDA Amiloride · Pediatric UseFDA Amiloride · Geriatric UseFDA Amiloride · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1520/Amiloride
- Clinical review⚠ Unverified